Zach W. Hall
Corporate Officer/Principal bei NeuroVentures Capital LLC
Aktive Positionen von Zach W. Hall
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
NeuroVentures Capital LLC
 NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital LLC (NeuroVenture Capital) is a venture capital firm founded in 1999 by Mark A. Cochran, Daniel J. O'Connell and Hans von Celsing. The firm is headquartered in Charlottesville, Virginia. | Corporate Officer/Principal | - | - |
Karriereverlauf von Zach W. Hall
Ehemalige bekannte Positionen von Zach W. Hall
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Nitrase Therapeutics, Inc.
 Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Direktor/Vorstandsmitglied | - | - |
| The University of California, San Francisco | Corporate Officer/Principal | - | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sektoral
| Finance | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
NeuroVentures Capital LLC
NeuroVentures Capital LLC Investment ManagersFinance NeuroVentures Capital LLC (NeuroVenture Capital) is a venture capital firm founded in 1999 by Mark A. Cochran, Daniel J. O'Connell and Hans von Celsing. The firm is headquartered in Charlottesville, Virginia. | Finance |
Nitrase Therapeutics, Inc.
Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Commercial Services |
- Börse
- Insiders
- Zach W. Hall
- Erfahrung
